XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 26, 2017
Mar. 27, 2016
Cash flows from operating activities:    
Net income $ 62,469 $ 45,451
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 9,498 8,221
Losses on sale/disposal of assets 182 86
Amortization of debt issuance costs 1,400 1,660
Provision for deferred income taxes 6,232 4,397
Non-cash compensation expense 5,220 4,898
Other (52) 135
Excess tax benefits from equity-based compensation (6,498) (31,896)
Changes in operating assets and liabilities 7,242 (15,804)
Net cash provided by operating activities 85,693 17,148
Cash flows from investing activities:    
Capital expenditures (12,444) (10,486)
Proceeds from sale of assets 779 1,742
Changes in restricted cash (39,170) 26,817
Other 544 (587)
Net cash provided by (used in) investing activities (50,291) 17,486
Cash flows from financing activities:    
Repayments of long-term debt and capital lease obligations (9,718) (27,459)
Proceeds from exercise of stock options 1,433 9,182
Excess tax benefits from equity-based compensation   31,896
Purchases of common stock (12,721)  
Tax payments for restricted stock upon vesting (4,896) (3,036)
Payments of common stock dividends and equivalents (253) (164)
Net cash provided by (used in) financing activities (26,155) 10,419
Effect of exchange rate changes on cash and cash equivalents 32 (250)
Change in cash and cash equivalents 9,279 44,803
Cash and cash equivalents, at beginning of period 42,815 [1] 133,449
Cash and cash equivalents, at end of period $ 52,094 $ 178,252
[1] Note: The balance sheet at January 1, 2017 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.